A previously unsuspected genetic mechanism underlies a type of muscular dystrophy common in Japan. A therapeutic approach based on this finding and tested in mice has come up with encouraging results. See Letter p.127
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fukuyama, Y., Osawa, M. & Suzuki, H. Brain Dev. 3, 1–29 (1981).
Taniguchi-Ikeda, M. et al. Nature 478, 127–131 (2011).
Toda, T. & Kobayashi, K. J. Mol. Med. 77, 816–823 (1999).
Xing, J. et al. Genome Res. 19, 1516–1526 (2009).
Hayashi, Y. K. et al. Neurology 57, 115–121 (2001).
Michele, D. E. et al. Nature 418, 417–422 (2002).
Kobayashi, K. et al. Nature 394, 388–392 (1998).
Hancks, D. C., Ewing, A. D., Chen, J. E., Tokunaga, K. & Kazazian, H. H. Jr Genome Res. 19, 1983–1991 (2009).
Dominski, Z. & Kole, R. Proc. Natl Acad. Sci. USA 90, 8673–8677 (1993).
Muntoni, F. & Wood, M. J. A. Nature Rev. Drug Discov. 10, 621–637 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamori, M., Thornton, C. A hidden ancestral legacy trumped. Nature 478, 46–47 (2011). https://doi.org/10.1038/478046a
Published:
Issue Date:
DOI: https://doi.org/10.1038/478046a